UroGen (URGN) 2025 Earnings: What Investors Should Know
As UroGen prepares to report 2025 results, investors weigh Jelmyto sales, pipeline progress, and balance-sheet health...
Index funds vary in tax efficiency; choosing the right ones can lower taxable gains and boost after-tax returns. This guide covers tax-smart picks and strategies.
24,188 articlesAs UroGen prepares to report 2025 results, investors weigh Jelmyto sales, pipeline progress, and balance-sheet health...
A leading tech investor envisions a future where AI-enabled labor trims traditional work yet expands access to essent...
A sharp February pullback put Intel back in focus. This guide breaks down the drivers, the long-term thesis, and how ...
As AI, cloud, and cybersecurity accelerate, five hyper-growth tech stocks 2026 could power a bold investment portfoli...
Even with rising mortgage costs and tight supply, single women are buying homes at record levels, redefining ownershi...
Visa is more than a brand name. This article explores whether could buying visa stock make sense for long-term wealth...
Large Bitcoin holders are stepping back into accumulation as BTC hovers near $71,000, a move that could signal renewe...
The trade desk stock swung sharply today as a major client questioned DSP usage. This piece breaks down what happened...
Centuri Holdings ends 2025 with a booming backlog and falling debt, yet investors face a high bar to justify lofty va...
Hims & Hers is weighing a bold strategy that could change how obesity treatment is sold. A new partnership and drug l...
A letter allegedly from Sam Bankman-Fried is under intense scrutiny as prosecutors question its authenticity. Amid fa...
As Lumentum and Coherent rally, Onto Innovation could be the next optics supplier to gain. Analysts say the surge ref...